AAAAAA

   
Results: 1-9 |
Results: 9
RECENT DEVELOPMENTS IN MOLECULAR ACTION OF ANTIHORMONES
Authors: FUHRMANN U PARCZYK K KLOTZBUCHER M KLOCKER H CATO ACB
Citation: U. Fuhrmann et al., RECENT DEVELOPMENTS IN MOLECULAR ACTION OF ANTIHORMONES, Journal of molecular medicine, 76(7), 1998, pp. 512-524
PROGESTERONE-RECEPTOR REPRESSION BY ESTROGENS IN RAT UTERINE EPITHELIAL-CELLS
Authors: PARCZYK K MADJNO R MICHNA H NISHINO Y SCHNEIDER RR
Citation: K. Parczyk et al., PROGESTERONE-RECEPTOR REPRESSION BY ESTROGENS IN RAT UTERINE EPITHELIAL-CELLS, Journal of steroid biochemistry and molecular biology, 63(4-6), 1997, pp. 309-316
IN-VITRO AND ANIMAL STUDIES WITH ANTIPROGESTINS
Authors: MICHNA H NISHINO Y PARCZYK K SCHNEIDER MR
Citation: H. Michna et al., IN-VITRO AND ANIMAL STUDIES WITH ANTIPROGESTINS, Breast, 5(3), 1996, pp. 224-228
THE FUTURE OF ANTIHORMONE THERAPY - INNOVATIONS BASED ON AN ESTABLISHED PRINCIPLE
Authors: PARCZYK K SCHNEIDER MR
Citation: K. Parczyk et Mr. Schneider, THE FUTURE OF ANTIHORMONE THERAPY - INNOVATIONS BASED ON AN ESTABLISHED PRINCIPLE, Journal of cancer research and clinical oncology, 122(7), 1996, pp. 383-396
RELATION OF ESTRADIOL-MEDIATED GROWTH-STIMULATION WITH THE EXPRESSIONOF C-ERBB-2 PROTEIN IN XENOTRANSPLANTED ESTRADIOL-RECEPTOR-POSITIVE AND ESTRADIOL-RECEPTOR-NEGATIVE BREAST CARCINOMAS
Authors: NAUNDORF H PARCZYK K ZSCHIESCHE W REINECKE S BUTTNER B SAUL GJ SINN B FICHTNER I
Citation: H. Naundorf et al., RELATION OF ESTRADIOL-MEDIATED GROWTH-STIMULATION WITH THE EXPRESSIONOF C-ERBB-2 PROTEIN IN XENOTRANSPLANTED ESTRADIOL-RECEPTOR-POSITIVE AND ESTRADIOL-RECEPTOR-NEGATIVE BREAST CARCINOMAS, Journal of cancer research and clinical oncology, 122(1), 1996, pp. 14-20
ANTIPROGESTINS INHIBIT GROWTH AND STIMULATE DIFFERENTIATION IN THE NORMAL MAMMARY-GLAND
Authors: LI ML SPITZER E ZSCHIESCHE W BINAS B PARCZYK K GROSSE R
Citation: Ml. Li et al., ANTIPROGESTINS INHIBIT GROWTH AND STIMULATE DIFFERENTIATION IN THE NORMAL MAMMARY-GLAND, Journal of cellular physiology, 164(1), 1995, pp. 1-8
ESTROGEN ACTION ON HEPATIC SYNTHESIS OF ANGIOTENSINOGEN AND IGF-I - DIRECT AND INDIRECT ESTROGEN EFFECTS
Authors: KRATTENMACHER R KNAUTHE R PARCZYK K WALKER A HILGENFELDT U FRITZEMEIER KH
Citation: R. Krattenmacher et al., ESTROGEN ACTION ON HEPATIC SYNTHESIS OF ANGIOTENSINOGEN AND IGF-I - DIRECT AND INDIRECT ESTROGEN EFFECTS, Journal of steroid biochemistry and molecular biology, 48(2-3), 1994, pp. 207-214
DIFFERENTIATION THERAPY WITH THE PROGESTERONE ANTAGONIST ONAPRISTONE IN EXPERIMENTAL BREAST AND PROSTATE-CANCER
Authors: MICHNA H SCHNEIDER M GEHRING S PARCZYK K
Citation: H. Michna et al., DIFFERENTIATION THERAPY WITH THE PROGESTERONE ANTAGONIST ONAPRISTONE IN EXPERIMENTAL BREAST AND PROSTATE-CANCER, Journal of cellular biochemistry, 1994, pp. 238-238
GP80 (CLUSTERIN, TRPM-2) MESSENGER-RNA LEVEL IS ENHANCED IN HUMAN RENAL CLEAR-CELL CARCINOMAS
Authors: PARCZYK K PILARSKY C RACHEL U KOCHBRANDT C
Citation: K. Parczyk et al., GP80 (CLUSTERIN, TRPM-2) MESSENGER-RNA LEVEL IS ENHANCED IN HUMAN RENAL CLEAR-CELL CARCINOMAS, Journal of cancer research and clinical oncology, 120(3), 1994, pp. 186-188
Risultati: 1-9 |